Thermo Fisher Scientific to expand biopharma manufacturing infrastructure in India
Company to establish Bioprocess Design Centre and Customer Experience Centre in Hyderabad by 2025 to strengthen India’s biopharma…
Author
Japanese researchers develop cerium-based method to enable multiple chemical reactions in one vessel
A team from Chiba University introduces redox-adaptive auto-tandem catalysis, using cerium to sequentially perform two reactions…
Why pharma needs an HRMS built for continuous learning
In this article, Sonali Chowdhry highlights why the pharmaceutical industry needs a Human Resource Management System (HRMS)…
Trinity Challenge Awards £1 million to projects tackling antibiotic resistance in Africa
Com-WATCH in Nigeria and PADs across five African countries win £500,000 each to improve community access to effective antibiotics…
NITI Aayog highlights rare diseases challenge affecting 90 million Indians at FICCI national…
Stakeholders from government, parliament, industry, and patient groups call for indigenous drug development, stronger registries,…
Indian immunologicals pledges 5 lakh anti-rabies vaccine doses under CSR initiative
The company will provide veterinary anti-rabies vaccines for free roaming dogs as part of its support to the "One Health" mission
India levels up in solving complex drug formulation challenges
Chetan Shah highlights how India’s pharmaceutical industry is advancing from bulk drug production to complex formulations,…
Alzheimer’s disease market to reach $17 billion in 8MM by 2033, forecasts GlobalData
GlobalData projects disease-modifying therapies, ageing populations, and new symptomatic treatments to drive Alzheimer’s disease…
Extrovis AG and Dr Reddy’s launch authorised generic Fluorouracil Cream 0.5 per cent in US market
The authorised generic of Carac (fluorouracil cream) 0.5 per cent is approved by the USFDA and manufactured in Texas for the…
NATCO Pharma launches generic Bosentan tablets for oral suspension in the United States
NATCO partners with Lupin for Bosentan tablets, gains 180-day exclusivity for pulmonary arterial hypertension treatment in…